Details
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationRanked by rounds participated in, from announcements in Sep 24, 2026 – Oct 23, 2026. Lead counts include only confirmed lead roles.
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationNew companies 7 · Follow-on 1
Stages: Undisclosed 8
Riverlane Undisclosed Planned strategic investmentForesight Undisclosed Planned strategic investmentHiverge Undisclosed Planned strategic investmentNew companies 5 · Follow-on 0
Stages: Series A 2, Seed 1, Series B 1, Series C+ 1
Nouscom €120M Series DCarbonFarm €7M Series AEdonia €15M Series A financing package including non-dilutive and bank fundingNew companies 4 · Follow-on 0
Stages: Undisclosed 2, Pre-seed 1, Seed 1
Emerald £1.4M Grant and venture fundingGo Eve Undisclosed UndisclosedAffinity Labs $2M Pre-seed funding including grantNew companies 4 · Follow-on 0
Stages: Seed 2, Pre-seed 1, Series B 1
Rabot Energy $50M Series BTODAY €2.8M SeedFinches €2M Pre-seedNew companies 3 · Follow-on 1
Stages: Undisclosed 3, Series A 1
PSV Tech Fund II €56M Fund II, final close October 2026Rodinia Generation €4M Investment roundSovera Security DKK 4M EIFO match loanNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Undisclosed 1
Indurex €7M Undisclosedreebuild €3M SeedDuqu €1.5M Pre-seedNew companies 3 · Follow-on 0
Stages: Pre-seed 3
Jenz €540K Pre-seedAffinity Labs $2M Pre-seed funding including grantCodeWall $4M Pre-seedNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Undisclosed 1
Opply $7.5M UndisclosedDuvo $32M Series ASpiko $90M Series BNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
Opply $7.5M UndisclosedCori Clinical $4M SeedNettle $4.8M SeedNew companies 3 · Follow-on 0
Stages: Seed 2, Series C+ 1
Nouscom €120M Series DAptadir Therapeutics €40M SeedClastix €2.9M SeedNew companies 2 · Follow-on 1
Stages: Pre-seed 2, Series C+ 1
Vessla $3.3M Pre-seedSolvera $6.3M Pre-seedMetaview $60M Series CNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
Microbiotica £36M Series C first closeOMass Therapeutics $310M Series CSalience Labs $125M Series BNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Undisclosed 1
Ambio €5.1M Seed1KOMMA5° ~€70M Equity financingProcuros €20M Series ANew companies 3 · Follow-on 0
Stages: Series B 2, Seed 1
Rabot Energy $50M Series BRivercell $25M SeedHadrian $40M Series BNew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Series B 1
Causa Prima $20M SeedScarlet $50M Series BProcuros €20M Series ANew companies 3 · Follow-on 0
Stages: Undisclosed 2, Seed 1
Wavo €10M Equity financing1KOMMA5° ~€70M Equity financingComplaion €13.5M SeedNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
HyLight €13M Funding roundSensible Biotechnologies $47M Series ARevnu $3M SeedNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
IMMIX $3.5M UndisclosedCleavr €8M SeedNettle $4.8M SeedNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series A 1
Sensible Biotechnologies $47M Series AFoundational £8.2M Pre-seedZenithon AI $10M SeedNew companies 2 · Follow-on 1
Stages: Pre-seed 2, Seed 1
Cleavr €8M SeedFleuret AI €4M Pre-seedDoD Solution $2.1M Pre-SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
QuantrolOx €12M Series AReverion $175M Series BNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
Enact Intelligence $30M Pre-seedScarlet $50M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Opply $7.5M UndisclosedScarlet $50M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.